Virtual West Oncology Conference


 

ASH Updates on Lymphomas: Bispecific Antibodies for Patients Who Relapse After CAR-T or ASCT, CAR-T & Bispecific Antibodies for Indolent Lymphomas

109 views
March 8, 2021
Comments 0
Login to view comments. Click here to Login